A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab

A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab

ABSTRACT Background The combination of nivolumab and ipilimumab, which act on different immune checkpoint molecules, is a promising first‐line treatment strategy for advanced nonsmall cell lung cancer (NSCLC). However, real‐world clinical data on this regimen, particularly regarding the relationship...

Full description

Saved in:
Bibliographic Details
Main Authors: Atsuto Mouri, Hisao Imai, Satoshi Endo, Junichi Nakagawa, Kasumi Tsukamoto, Yuhei Kurata, Ou Yamaguchi, Kenji Masaki, Kosuke Hashimoto, Ayako Shiono, Yu Miura, Kunihiko Kobayashi, Kyoichi Kaira, Hiroshi Kagamu
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Cancer Medicine
Subjects:
freal‐world
immune‐related adverse events
ipilimumab
nivolumab
nonsmall cell lung cancer
Online Access:https://doi.org/10.1002/cam4.70741
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.70741

Similar Items